Katie Stone

1.5k total citations
20 papers, 640 citations indexed

About

Katie Stone is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Katie Stone has authored 20 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Katie Stone's work include Viral-associated cancers and disorders (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Katie Stone is often cited by papers focused on Viral-associated cancers and disorders (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Katie Stone collaborates with scholars based in United States, Belgium and France. Katie Stone's co-authors include Frits van Rhee, Kristine E. Ensrud, S. R. Cummings, Douglas C. Bauer, Dennis M. Black, Bart Barlogie, Susann Szmania, Zeba N. Singh, Amy D Greenway and Michael C. Nevitt and has published in prestigious journals such as Blood, PLoS ONE and Journal of Bone and Mineral Research.

In The Last Decade

Katie Stone

20 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katie Stone United States 10 393 218 204 128 118 20 640
Eugénie Koumakis France 15 148 0.4× 129 0.6× 199 1.0× 134 1.0× 21 0.2× 39 674
Kaichi Kaneko Japan 14 98 0.2× 52 0.2× 30 0.1× 160 1.3× 34 0.3× 41 499
Ben Ponvilawan United States 13 73 0.2× 22 0.1× 71 0.3× 80 0.6× 48 0.4× 75 445
Gennaro De Rosa Italy 10 101 0.3× 50 0.2× 51 0.3× 52 0.4× 23 0.2× 16 314
Hankui Lu China 12 127 0.3× 33 0.2× 72 0.4× 73 0.6× 29 0.2× 31 430
D.J. Leeming Denmark 9 139 0.4× 121 0.6× 31 0.2× 138 1.1× 15 0.1× 17 404
Rasho Rashkov Bulgaria 12 66 0.2× 96 0.4× 50 0.2× 74 0.6× 24 0.2× 47 475
Priyanka Singh India 15 189 0.5× 53 0.2× 83 0.4× 185 1.4× 35 0.3× 42 687
Yoshihisa Morishita Japan 12 132 0.3× 40 0.2× 42 0.2× 104 0.8× 22 0.2× 36 414
I Yamamoto Japan 10 215 0.5× 86 0.4× 52 0.3× 138 1.1× 43 0.4× 30 462

Countries citing papers authored by Katie Stone

Since Specialization
Citations

This map shows the geographic impact of Katie Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Stone more than expected).

Fields of papers citing papers by Katie Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Stone. The network helps show where Katie Stone may publish in the future.

Co-authorship network of co-authors of Katie Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Stone. A scholar is included among the top collaborators of Katie Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Stone. Katie Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stone, Katie, et al.. (2024). Endometrial compaction to predict pregnancy outcomes in patients undergoing assisted reproductive technologies: a systematic review and meta-analysis. Human Reproduction Open. 2024(3). hoae040–hoae040. 3 indexed citations
2.
Nabel, Christopher S., Stephen Sameroff, Dustin Shilling, et al.. (2019). Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease. PLoS ONE. 14(6). e0218660–e0218660. 27 indexed citations
3.
Mohan, Meera, Mary E. Meek, Katie Stone, et al.. (2018). Treatment of Unresectable Unicentric Castleman Disease with Therapeutic Embolization. Blood. 132(Supplement 1). 2415–2415. 1 indexed citations
4.
Pierson, Sheila K., Aaron J. Stonestrom, Dustin Shilling, et al.. (2018). Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease. American Journal of Hematology. 93(7). 902–912. 60 indexed citations
5.
Johnson, Sadie, Stephen Burke, Amy D Greenway, et al.. (2018). Characterization of the Immune Impact of Daratumumab By Mass Cytometry in Multiple Myeloma. Blood. 132(Supplement 1). 4466–4466. 1 indexed citations
6.
Stone, Katie, et al.. (2018). Personalized Therapy in Multicentric Castleman Disease Produces Excellent Outcomes in a Tertiary Referral Center. Blood. 132(Supplement 1). 3701–3701. 1 indexed citations
7.
Garg, Tarun K., Katie Stone, Amy D Greenway, et al.. (2017). The IL15 Superagonist Complex ALT-803 Potently Enhances the Proliferative Capacity and Activity of in Vitro Expanded Natural Killer Cells. Blood. 130. 5452–5452. 1 indexed citations
8.
Rhee, Frits van, Amy D Greenway, & Katie Stone. (2017). Treatment of Idiopathic Castleman Disease. Hematology/Oncology Clinics of North America. 32(1). 89–106. 43 indexed citations
9.
Liu, Yi‐Chang, Katie Stone, & Frits van Rhee. (2014). Siltuximab for multicentric Castleman disease. Expert Review of Hematology. 7(5). 545–557. 13 indexed citations
10.
Stone, Katie, Susann Szmania, Owen Stephens, et al.. (2013). Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels. PLoS ONE. 8(1). e54610–e54610. 41 indexed citations
11.
Garg, Tarun K., Ricky D. Edmondson, Junaid Khan, et al.. (2013). Multiple Myeloma Cells Modulate ICAM-3 To Evade Natural Killer Cell-Mediated Lysis. Blood. 122(21). 3105–3105. 1 indexed citations
12.
Szmania, Susann, Natalia Lapteva, Tarun K. Garg, et al.. (2012). Expanded Natural Killer (NK) Cells for Immunotherapy: Fresh and Made to Order. Blood. 120(21). 1912–1912. 2 indexed citations
13.
Moreno-Bost, Amberly, Susann Szmania, Katie Stone, et al.. (2010). Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103. Cytotherapy. 13(5). 618–628. 27 indexed citations
14.
Rhee, Frits van, Katie Stone, Susann Szmania, Bart Barlogie, & Zeba N. Singh. (2010). Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy.. PubMed. 8(7). 486–98. 115 indexed citations
15.
Garg, Tarun K., Susann Szmania, Katie Stone, et al.. (2009). Adoptively Transferred Expanded Natural Killer Cells Inhibit Myeloma Tumor Growth In Vivo.. Blood. 114(22). 953–953. 1 indexed citations
16.
Garg, Tarun K., Susann Szmania, Jumei Shi, et al.. (2008). Ex Vivo Activated Natural Killer (NK) Cells from Myeloma Patients Kill Autologous Myeloma and Killing Is Enhanced by Elotuzumab. Blood. 112(11). 3666–3666. 3 indexed citations
17.
Moreno-Bost, Amberly, Susann Szmania, Katie Stone, et al.. (2008). Recognition of Myeloma by MAGE-A3 Specific Cytotoxic T Lymphocytes Induced by Treatment with Azacitidine and MGCD0103. Blood. 112(11). 3674–3674. 1 indexed citations
18.
Szmania, Susann, Sacha Gnjatic, Guido Tricot, et al.. (2007). Immunization With a Recombinant MAGE-A3 Protein After High-dose Therapy for Myeloma. Journal of Immunotherapy. 30(8). 847–854. 32 indexed citations
19.
Bauer, Douglas C., Katie Stone, Dennis M. Black, et al.. (1999). Biochemical Markers of Bone Turnover and Prediction of Hip Bone Loss in Older Women: The Study of Osteoporotic Fractures. Journal of Bone and Mineral Research. 14(8). 1404–1410. 139 indexed citations
20.
Stone, Katie, et al.. (1998). Hormonal Predictors of Bone Loss in Elderly Women: A Prospective Study. Journal of Bone and Mineral Research. 13(7). 1167–1174. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026